leisure time -WSS

leisure time

author：explore 2025-09-27 13:05:27 - browse：446

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The debate over Covid

explore

WSS

EU fines Illumina $475 million over Grail acquisition

Superbugs, antibiotic resistance get scrutiny in congress

Watch the official trailer for 'Ahsoka' series

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

White House drug shortages task force keeps mum with Congress

After John Oliver segment, STAT readers share their opioid

entertainment

leisure time

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Vermont grapples with historic flooding as more rainstorms head for Northeast

FDA approval of Sarepta Duchenne genetic therapy gives me hope

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cuban government calls US nuclear submarine stop a 'provocative escalation'

ChatGPT in medicine: STAT answers readers' burning questions

TB outbreak tied to bone grafts underscores testing shortcomings

Drug repurposing or repositioning? The language matters

After John Oliver segment, STAT readers share their opioid

entertainment

EU fines Illumina $475 million over Grail acquisition

Watch the official trailer for 'Ahsoka' series

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Companies helping big Covid

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

explore

knowledge

focus

entertainment